Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Immunogen Inc. buy BMO Capital Markets

Immunogen Inc.
Start price
€16.22
01.08.23 / 50%
Target price
€23.69
01.08.24
Performance (%)
78.61%
End price
-
02.08.24
Summary
This prediction is currently being closed. The BUY prediction by BMO_Capital_Markets for Immunogen Inc. has seen massive gains of 78.61%. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Immunogen Inc. - - - -
iShares Core DAX® 0,88 % 5,63 % 8,48 % 63,92 %
iShares Nasdaq 100 2,39 % 1,57 % 28,41 % 91,99 %
iShares Nikkei 225® 4,27 % 2,52 % 50,98 % 83,96 %
iShares S&P 500 1,17 % 2,55 % 23,60 % 71,36 %

Comments by BMO_Capital_Markets for this prediction

In the thread Immunogen Inc. diskutieren
Prediction Buy
Perf. (%) 78.61%
Target price 23.694
Change
Ends at 01.08.24

ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at BMO Capital Markets from $25.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for IMGN provided by MarketBeat

BMO Capital Markets 
0
Report Share
01.08.23
In the thread Trading Immunogen Inc.
Prediction Buy
Perf. (%) 78.61%
Target price 23.694
Change
Ends at 01.08.24

Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten

BMO Capital Markets 
0
Report Share
02.08.24